Kimberly Manhard - Net Worth and Insider Trading
Kimberly Manhard Net Worth
The estimated net worth of Kimberly Manhard is at least $173,955 dollars as of 2024-11-13. Kimberly Manhard is the Director of Inhibrx Biosciences Inc and owns about 10,000 shares of Inhibrx Biosciences Inc (INBX) stock worth over $160,800. Kimberly Manhard is also the EVP, Drug Development of Heron Therapeutics Inc and owns about 10,872 shares of Heron Therapeutics Inc (HRTX) stock worth over $13,155. Details can be seen in Kimberly Manhard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kimberly Manhard has not made any transactions after 2024-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kimberly Manhard
Kimberly Manhard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kimberly Manhard owns 2 companies in total, including Heron Therapeutics Inc (HRTX) , and Inhibrx Inc (INBX) .
Click here to see the complete history of Kimberly Manhard’s form 4 insider trades.
Insider Ownership Summary of Kimberly Manhard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2022-05-03 | director |
| INBX | Inhibrx Inc | 2020-08-18 | director |
Kimberly Manhard Latest Holdings Summary
Kimberly Manhard currently owns a total of 2 stocks. Among these stocks, Kimberly Manhard owns 10,000 shares of Inhibrx Biosciences Inc (INBX) as of August 28, 2024, with a value of $160,800 and a weighting of 92.44%. Kimberly Manhard also owns 10,872 shares of Heron Therapeutics Inc (HRTX) as of May 3, 2022, with a value of $13,155 and a weighting of 7.56%.
Latest Holdings of Kimberly Manhard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences Inc | 2024-08-28 | 10,000 | 16.08 | 160,800 |
| HRTX | Heron Therapeutics Inc | 2022-05-03 | 10,872 | 1.21 | 13,155 |
Holding Weightings of Kimberly Manhard
Kimberly Manhard Form 4 Trading Tracker
According to the SEC Form 4 filings, Kimberly Manhard has made a total of 1 transactions in Inhibrx Biosciences Inc (INBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inhibrx Biosciences Inc is the acquisition of 10,000 shares on August 28, 2024, which cost Kimberly Manhard around $139,800.
According to the SEC Form 4 filings, Kimberly Manhard has made a total of 5 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Heron Therapeutics Inc is the sale of 1,504 shares on May 3, 2022, which brought Kimberly Manhard around $7,159.
Insider Trading History of Kimberly Manhard
- 1
Kimberly Manhard Trading Performance
GuruFocus tracks the stock performance after each of Kimberly Manhard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kimberly Manhard is %. GuruFocus also compares Kimberly Manhard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kimberly Manhard within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kimberly Manhard's insider trading performs compared to the benchmark.
Performance of Kimberly Manhard
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.17 |  | | | | |
| Relative Return to S&P 500(%) | 8.56 | | | | | |
Kimberly Manhard Ownership Network
Ownership Network List of Kimberly Manhard
Ownership Network Relation of Kimberly Manhard
Kimberly Manhard Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
Kimberly Manhard is the director of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc (HRTX) Insider Trades Summary
Over the past 18 months, Kimberly Manhard made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
Kimberly Manhard Mailing Address
Above is the net worth, insider trading, and ownership report for Kimberly Manhard. You might contact Kimberly Manhard via mailing address: C/o Heron Therapeutics, Inc, 4242 Campus Point Court, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
